1034 related articles for article (PubMed ID: 26564165)
1. Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.
Wang J; Hao J; Bai D; Gu Q; Han W; Wang L; Tan Y; Li X; Xue K; Han P; Liu Z; Jia Y; Wu J; Liu L; Wang L; Li W; Liu Z; Zhou Q
Stem Cell Res Ther; 2015 Nov; 6():223. PubMed ID: 26564165
[TBL] [Abstract][Full Text] [Related]
2. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming of human fibroblasts to induced pluripotent stem cells under xeno-free conditions.
Rodríguez-Pizà I; Richaud-Patin Y; Vassena R; González F; Barrero MJ; Veiga A; Raya A; Izpisúa Belmonte JC
Stem Cells; 2010 Jan; 28(1):36-44. PubMed ID: 19890879
[TBL] [Abstract][Full Text] [Related]
4. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
[TBL] [Abstract][Full Text] [Related]
5. Generation of human induced pluripotent stem cells using genome integrating or non-integrating methods.
Šimara P; Tesařová L; Padourová S; Koutná I
Folia Biol (Praha); 2014; 60 Suppl 1():85-9. PubMed ID: 25369347
[TBL] [Abstract][Full Text] [Related]
6. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
[TBL] [Abstract][Full Text] [Related]
7. Generation of Storable Retinal Organoids and Retinal Pigmented Epithelium from Adherent Human iPS Cells in Xeno-Free and Feeder-Free Conditions.
Reichman S; Slembrouck A; Gagliardi G; Chaffiol A; Terray A; Nanteau C; Potey A; Belle M; Rabesandratana O; Duebel J; Orieux G; Nandrot EF; Sahel JA; Goureau O
Stem Cells; 2017 May; 35(5):1176-1188. PubMed ID: 28220575
[TBL] [Abstract][Full Text] [Related]
8. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
Xiong Y; Liu Y; Ge J
Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
[TBL] [Abstract][Full Text] [Related]
9. Xeno-Free Reprogramming of Peripheral Blood Mononuclear Erythroblasts on Laminin-521.
Skorik C; Mullin NK; Shi M; Zhang Y; Hunter P; Tang Y; Hilton B; Schlaeger TM
Curr Protoc Stem Cell Biol; 2020 Mar; 52(1):e103. PubMed ID: 31977148
[TBL] [Abstract][Full Text] [Related]
10. Electrospun polystyrene scaffolds as a synthetic substrate for xeno-free expansion and differentiation of human induced pluripotent stem cells.
Leong MF; Lu HF; Lim TC; Du C; Ma NKL; Wan ACA
Acta Biomater; 2016 Dec; 46():266-277. PubMed ID: 27667015
[TBL] [Abstract][Full Text] [Related]
11. Robust production of human neural cells by establishing neuroepithelial-like stem cells from peripheral blood mononuclear cell-derived feeder-free iPSCs under xeno-free conditions.
Isoda M; Kohyama J; Iwanami A; Sanosaka T; Sugai K; Yamaguchi R; Matsumoto T; Nakamura M; Okano H
Neurosci Res; 2016 Sep; 110():18-28. PubMed ID: 27083781
[TBL] [Abstract][Full Text] [Related]
12. Derivation of GMP-compliant integration-free hiPSCs using modified mRNAs.
Durruthy JD; Sebastiano V
Methods Mol Biol; 2015; 1283():31-42. PubMed ID: 25304205
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of Human Fibroblasts with Non-integrating RNA Virus on Feeder-Free or Xeno-Free Conditions.
Lieu PT
Methods Mol Biol; 2015; 1330():47-54. PubMed ID: 26621588
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
16. Development and evaluation of a novel xeno-free culture medium for human-induced pluripotent stem cells.
Hua Y; Yoshimochi K; Li J; Takekita K; Shimotsuma M; Li L; Qu X; Zhang J; Sawa Y; Liu L; Miyagawa S
Stem Cell Res Ther; 2022 Jun; 13(1):223. PubMed ID: 35658933
[TBL] [Abstract][Full Text] [Related]
17. Generation of Human Induced Pluripotent Stem Cells Using a Defined, Feeder-Free Reprogramming System.
Park S; Mostoslavsky G
Curr Protoc Stem Cell Biol; 2018 May; 45(1):e48. PubMed ID: 30040234
[TBL] [Abstract][Full Text] [Related]
18. Genetic manipulation of human induced pluripotent stem cells.
Wang A; Liew CG
Curr Protoc Stem Cell Biol; 2012 Nov; Chapter 5():Unit 5B.2. PubMed ID: 23154936
[TBL] [Abstract][Full Text] [Related]
19. One-step derivation of cardiomyocytes and mesenchymal stem cells from human pluripotent stem cells.
Wei H; Tan G; Manasi ; Qiu S; Kong G; Yong P; Koh C; Ooi TH; Lim SY; Wong P; Gan SU; Shim W
Stem Cell Res; 2012 Sep; 9(2):87-100. PubMed ID: 22683798
[TBL] [Abstract][Full Text] [Related]
20. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
